Yale School Of Medicine

Treatments for type 1 diabetes must be tailored to the heterogeneity of disease physiology among patients, moving beyond population-based HbA1c measures to individualized glycemic time in targets, according to a speaker.

Saracatinib appeared to be “equal or superior” in stopping fibrotic responses compared with two FDA-approved antifibrotic drugs, according to a preclinical study published in American Journal of Respiratory and Critical Care Medicine.

Optimal sequencing of therapy for metastatic urothelial carcinoma will be crucial to extend patient survival, given the number of drug approvals over the past decade, according to a speaker at Chemotherapy Foundation Symposium.

Among adults hospitalized with acute MI, Black patients presented with a more “geriatric” phenotype with more functional impairments than white patients despite being younger, researchers reported.

PHILADELPHIA — Taking an “anatomy inventory” during visits can help cultivate a more supportive environment for transgender and non-binary patients to discuss their gender identity and the need for organ-specific care, a presenter here said.

CHICAGO — In MI survivors younger than 55 years, those who reported perceived discrimination had worse outcomes in the year after their MI vs. those who did not, researchers reported at the American Heart Association Scientific Sessions.

CHICAGO — Severe marital stress was associated with reduced physical and mental health and increased all-cause readmission in the 1 year following acute MI, a speaker reported.

Study results found a 1-year mortality rate of 13.4% after major surgery among community-living older adults in the United States, with the highest mortality rates seen in those who were frail and had probable dementia.

ANAHEIM, Calif. — Interactions between endocrine-disrupting chemicals and race may affect the elevated incidence of uterine fibroids among Black women, according to results presented here.

In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump was linked to lower odds of death, MI and cardiogenic shock compared with use of an intra-aortic balloon pump.